Cite
Bruxvoort KJ, Sy LS, Qian L, et al. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ. 2021;375:e068848doi: 10.1136/bmj-2021-068848.
Bruxvoort, K. J., Sy, L. S., Qian, L., Ackerson, B. K., Luo, Y., Lee, G. S., Tian, Y., Florea, A., Aragones, M., Tubert, J. E., Takhar, H. S., Ku, J. H., Paila, Y. D., Talarico, C. A., & Tseng, H. F. (2021). Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ (Clinical research ed.), 375e068848. https://doi.org/10.1136/bmj-2021-068848
Bruxvoort, Katia J, et al. "Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study." BMJ (Clinical research ed.) vol. 375 (2021): e068848. doi: https://doi.org/10.1136/bmj-2021-068848
Bruxvoort KJ, Sy LS, Qian L, Ackerson BK, Luo Y, Lee GS, Tian Y, Florea A, Aragones M, Tubert JE, Takhar HS, Ku JH, Paila YD, Talarico CA, Tseng HF. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study. BMJ. 2021 Dec 15;375:e068848. doi: 10.1136/bmj-2021-068848. PMID: 34911691.
Copy
Download .nbib